SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-296636
Filing Date
2019-11-20
Accepted
2019-11-20 16:46:10
Documents
14
Period of Report
2019-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834366d8k.htm   iXBRL 8-K 29592
2 EX-99.1 d834366dex991.htm EX-99.1 29694
6 GRAPHIC g834366g1121010850912.jpg GRAPHIC 3274
  Complete submission text file 0001193125-19-296636.txt   198626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alny-20191120.xsd EX-101.SCH 3068
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20191120_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20191120_pre.xml EX-101.PRE 11407
12 EXTRACTED XBRL INSTANCE DOCUMENT d834366d8k_htm.xml XML 3432
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 191234796
SIC: 2834 Pharmaceutical Preparations